Skip to main content
SpringerLink
Log in

Migraine in Children and Adolescents

A Guide to Drug Treatment

CNS Drugs Aims and scope Submit manuscript

Abstract

Migraine is a common disorder in children and adolescents, with a prevalence of 5 and 10%, respectively. Some patients may have recognisable factors that trigger or aggravate migraine attacks, such as flickering or bright lights, strong smells and noise, and where possible these should be avoided. It is also wise to maintain a lifestyle where children receive regular meals and get sufficient sleep. If used, acute pharmacological treatment should be given at the onset of an attack, followed by a rest or sleep. According to recent literature, paracetamol (acetaminophen) and ibuprofen can be recommended for the acute treatment of migraine attacks in children and adolescents, and sumatriptan nasal spray can be recommended for adolescents. The oral formulation of sumatriptan has not shown efficacy in paediatric patients, and the subcutaneous injection, although somewhat effective, is not an ideal formulation for this patient group. There are too few data on the efficacy of the other ‘triptans’ to recommend their use in children and adolescents. There are less data on the use of prophylactic drugs in paediatric patients. In systematic studies, only flunarizine, which is not available in many countries, and propranolol have been found to be effective. A pilot placebo-controlled study suggests that topiramate might also be effective. Several other agents are commonly used to prevent migraine attacks in children (e.g. amitriptyline, valproic acid [sodium valproate]) despite a lack of robust research into their efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

References

  1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994; 309: 765–9

    Article  PubMed  CAS  Google Scholar 

  2. Stafstrom CE, Rostasy K, Minster A. The usefulness of children’s drawings in the diagnosis of headache. Pediatrics 2002; 109: 460–72

    Article  PubMed  Google Scholar 

  3. Olesen J. The international classification of headache disorders. 2nd ed. Cephalalgia 2004; 24Suppl. 1: 9–160

    Article  Google Scholar 

  4. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002; 340: 257–70

    Google Scholar 

  5. Kropp P, Siniatchkin M, Gerber W-D. On the pathophysiology of migraine: links for “empirically based treatment” with neurofeedback. Appl Psychophysiol Biofeedback 2002; 27: 203–13

    Article  PubMed  Google Scholar 

  6. Millichap JG, Michelle MY. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003; 28: 9–15

    Article  PubMed  Google Scholar 

  7. Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992; 12: 238–43

    Article  PubMed  CAS  Google Scholar 

  8. Baumann RJ. Behavioral treatment of migraine in children and adolescents. Paediatr Drugs 2002; 4: 555–61

    PubMed  Google Scholar 

  9. Salfield SA, Wardley BL, Houlsby WT, et al. Controlled study of exclusion of dietary vasoactive amines in migraine. Arch Dis Child 1987; 62: 458–60

    Article  PubMed  CAS  Google Scholar 

  10. MacDonald A, Forsythe I, Wall C. Dietary treatment of migraine. In: Lanzi G, Balottin U, Cernibori A, editors. Headache in children and adolescents. Proceedings of the First International Symposium on Headache in Children and Adolescents: 1988 May 19–20; Pavia. Amsterdam: Elsevier Science Publishers BV, 1989: 333–8

    Google Scholar 

  11. Osterhaus S. Psychological treatment of paediatric headache. In: Arafeh I, editor. Childhood headache. London: MacKeith Press, 2002: 149–74

    Google Scholar 

  12. Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 1995; 60: 239–55

    Article  PubMed  CAS  Google Scholar 

  13. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology 1998; 50: 466–70

    Article  PubMed  CAS  Google Scholar 

  14. Wang F, Van Den Eeden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003; 43: 601–10

    Article  PubMed  Google Scholar 

  15. Lewis D, Ashwal S, Hershey A, et al. American Academy of Neurology Quality Standards Subcommittee. Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004; 63: 2215–24

    CAS  Google Scholar 

  16. Damen L, Bruijn JKJ, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics 2005; 116: 295–302

    Article  Google Scholar 

  17. Hämäläinen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997; 48: 103–7

    Article  PubMed  Google Scholar 

  18. Lewis DW, Kellstein D, Burke B, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine headache. Headache 2002; 42: 780–6

    Article  PubMed  Google Scholar 

  19. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study: do children with migraine respond to oral sumatriptan differently from adults? Neurology 1997; 48: 1100–3

    Article  PubMed  Google Scholar 

  20. Evers S. Drug treatment of migraine in children: a comparative review. Paediatr Drugs 1999; 1: 7–18

    Article  PubMed  CAS  Google Scholar 

  21. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999; 52: 1507–10

    Article  PubMed  CAS  Google Scholar 

  22. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106(5): 989–97

    Article  PubMed  CAS  Google Scholar 

  23. Ahonen K, Hämäläinen ML, Rantala H, et al. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 2004; 62: 893–87

    Article  Google Scholar 

  24. Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 2006; 46: 212–22

    Article  PubMed  Google Scholar 

  25. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994; 34: 581–2

    Article  PubMed  CAS  Google Scholar 

  26. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 1996; 36: 419–22

    Article  PubMed  CAS  Google Scholar 

  27. Winner P, Lewis D, Visser WH, et al. Rizatriptan 5mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache 2002; 42: 49–55

    Article  PubMed  Google Scholar 

  28. Linder SL, Dowson SJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract 2000; 54: 466–9

    PubMed  CAS  Google Scholar 

  29. Kabbouche MA, Vockell AL, LeCates SL, et al. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 2001; 107(4): E62

    Article  PubMed  CAS  Google Scholar 

  30. Brousseau DC, Duffy SJ, Anderson AC, et al. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004; 43: 256–62

    Article  PubMed  Google Scholar 

  31. Victor S, Ryan S. Drugs for preventing migraine headaches in children. Cochrane Database Syst Rev 2003; 4: CD002761

    PubMed  Google Scholar 

  32. Hershey AD, Powers SW, Vockell AL, et al. Effectiveness of topiramate in the prevention of childhood headaches. Headache 2002; 42: 810–8

    Article  PubMed  Google Scholar 

  33. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974; 50: 109–15

    Article  PubMed  CAS  Google Scholar 

  34. Sillanpää M. Clonidine prophylaxis of childhood migraine and other vascular headache: a double blind study of 57 children. Headache 1977; 17: 28–31

    Article  PubMed  Google Scholar 

  35. Sillanpää M, Koponen M. Papaverine in the prophylaxis of migraine and other vascular headache in children. Acta Paediatr Scand 1978; 67: 209–12

    Article  PubMed  Google Scholar 

  36. Forsythe WI, Gillies D, Sills MA. Propranolol (‘Inderal’) in the treatment of childhood migraine. Dev Med Child Neurol 1984; 26: 737–41

    Article  PubMed  CAS  Google Scholar 

  37. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987; 79: 593–7

    PubMed  CAS  Google Scholar 

  38. Sills M, Congdon P, Forsythe I. Clonidine in childhood migraine: a pilot and double-blind study. Dev Med Child Neurol 1982; 24: 837–41

    Article  PubMed  CAS  Google Scholar 

  39. Santucci M, Cortelli P, Rossi PG, et al. L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study. Cephalalgia 1986; 6: 155–7

    Article  PubMed  CAS  Google Scholar 

  40. Gillies D, Sills M, Forsythe I. Pizotifen (Sanomigran) in childhood migraine: a double-blind controlled trial. Eur Neurol 1986; 25: 32–5

    Article  PubMed  CAS  Google Scholar 

  41. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child 1995; 72: 48–50

    Article  PubMed  CAS  Google Scholar 

  42. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine: a double-blind study. Cephalalgia 1985; 5Suppl. 2: 145–8

    Google Scholar 

  43. Battistella PA, Ruffilli R, Moro R, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 1990; 30: 264–8

    Article  PubMed  CAS  Google Scholar 

  44. Battistella PA, Ruffilli R, Cernetti R, et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 1993; 33: 36–9

    Article  PubMed  CAS  Google Scholar 

  45. Caruso JM, Brown WD, Exil G, et al. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000; 40: 672–6

    Article  PubMed  CAS  Google Scholar 

  46. Pakalnis A, Greenberg G, Drake ME, et al. Pediatric migraine proplylaxis with divalproex. J Child Neurol 2001; 16: 731–4

    Article  PubMed  CAS  Google Scholar 

  47. Serdaroglu G, Erhan E, Tekgul H, et al. Sodium valproate prophylaxis in childhood migraine. Headache 2002; 42: 819–22

    Article  PubMed  Google Scholar 

  48. Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache 2004; 44: 238–43

    Article  PubMed  Google Scholar 

  49. Sorge F, Barone P, Steardo L, et al. Amitriptyline as a prophylactic for migraine in children. Acta Neurol (Napoli) 1982; 4: 362–7

    CAS  Google Scholar 

  50. Hershey AD, Powers SW, Bentti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40: 539-49

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

During the preparation of this article, the author worked, and is currently working as, a Paediatric Neurologist in the Helsinki University Central Hospital, Helsinki, Finland. No sources of funding were used to assist in the preparation of this review.

Author information

Authors and Affiliations

  1. Department of Pediatric Neurology, Hospital for Children and Adolescents, Helsinki University Central Hospital, PO Box 280, 00029, Helsinki, Finland

    Mirja L. Hämäläinen

Authors
  1. Mirja L. Hämäläinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hämäläinen, M.L. Migraine in Children and Adolescents. CNS Drugs 20, 813–820 (2006). https://doi.org/10.2165/00023210-200620100-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200620100-00003

Keywords

search

Navigation